![]() |
|
|
Forward to a colleague |
||
Access Full Stories China's drug watchdog has revealed its stance on drug exports from the country: the bottom line is buyer beware... Read AMRI stuck with stagnant sales AMRI edged back into the red during the fourth quarter of 2007 after stagnant sales growth and higher costs, a scenario that is expected to continue... Read Two CROs merge to take on Eastern Europe A Polish and a Czech firm have merged together in a bid to strengthen their position in the Central and Eastern Europe's (CEE's) budding clinical research scene... Read West reports profit slump on higher production costs West Pharmaceutical Services has reported sales of over $1bn in 2007 and is optimistic about 2008, despite a small drop in the consolidated gross profit margin large in Q4. ... Read PRA expands pharmacology capabilities PRA International has just expanded its Phase I capabilities with the opening of a new clinical pharmacology facility in Kansas, US... Read |
||||||||||||||
All News Headlines for: February | January | December |
||||||||||||||
![]() Contract Biotechnology And Sterile Pharmaceutical Manufacturing Services Catalent Pharma Solutions offers a full range of manufacturing services from clinical through commercial-scale manufacturing and packaging. Multiple sites, capacity duplication and experience with almost every sterile dose form, make us the best choice for pharmaceutical... Click Here | ||||||||||||||
|
Related Industry News Novartis vaccines institute sets sights on developing world diseases Novartis has lent impetus to the growing trend towards philanthropic R&D in the pharmaceutical industry by opening a new research institute in Siena, Italy "with a non-profit mission to exclusively focus on... Read BASF sees hefty chemicals growth in 2007 Earnings growth from its pharma solutions business helped push BASF's operating income (EBITDA) from fine chemicals up by 56.5 per cent to €288m in 2007... Read Accu-Break goes for gold with Midas tie-up for Europe Accu-Break Pharmaceuticals (ABP) has signed a co-operation agreement with Germany's Midas Pharma that should open new avenues for its divisible dosage form technologies in Europe. ... Read Genmab slakes capacity thirst with PDL facility purchase Genmab, the Danish antibody specialist with three product candidates in Phase III clinical trials, is taking control of its manufacturing requirements with the agreed acquisition of an antibody facility in Minnesota,... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||